Search

Your search keyword '"Ek, S"' showing total 376 results

Search Constraints

Start Over You searched for: Author "Ek, S" Remove constraint Author: "Ek, S"
376 results on '"Ek, S"'

Search Results

151. Empowering macrophages: the cancer fighters within the tumour microenvironment in mantle cell lymphoma.

152. [Prescription of osteoporosis drugs and secondary fracture prevention still at low levels and with large regional variation].

153. Antidepressants and the Risk of Ischemic Stroke in Older Adults According to the Degree of Serotonin Reuptake Inhibition: A Retrospective Cohort Study.

154. A short length of hospital stay is not associated with risk of readmission among hip fracture patients - a Swedish national register-based cohort study.

155. A Web-Based Total Worker Health Intervention for Those Fighting Wildland Fires: Mixed Methods Development and Effectiveness Trial.

156. Population frailty trends by education and income levels over a period of 30 years: findings from Swedish registry data.

157. Soluble CD163 predicts outcome in both chemoimmunotherapy and targeted therapy-treated mantle cell lymphoma.

158. Technology-Enabled Intervention to Enhance Mindfulness, Safety, and Health Promotion Among Corrections Professionals: Protocol for a Prospective Quasi-Experimental Trial.

159. Secondary fracture prevention with osteoporosis medication after a fragility fracture in Sweden remains low despite new guidelines.

160. Frailty Among Breast Cancer Survivors: Evidence From Swedish Population Data.

161. Exploring new prognostic biomarkers in Mantle Cell Lymphoma: a comparison of the circSCORE and the MCL35 score.

162. Phenotypic characterization of spatial immune infiltration niches in non-small cell lung cancer.

163. Site-1 protease inhibits mitochondrial respiration by controlling the TGF-β target gene Mss51.

164. Spatially Guided and Single Cell Tools to Map the Microenvironment in Cutaneous T-Cell Lymphoma.

165. Transitioning from conventional photon therapy to proton therapy for primary brain tumors.

166. Overexpression of the key metabolic protein CPT1A defines mantle cell lymphoma patients with poor response to standard high-dose chemotherapy independent of MIPI and complement established highrisk factors.

167. Can the 1-Leg Standing Test Be Replaced by Self-reported Balance in the First-Time Injurious Fall Screening Tool?

168. SOX11 regulates SWI/SNF complex components as member of the adrenergic neuroblastoma core regulatory circuitry.

169. Waiting more than 24 hours for hip fracture surgery is associated with increased risk of adverse outcomes for sicker patients: a nationwide cohort study of 63,998 patients using the Swedish Hip Fracture Register.

170. Trends in Frailty Between 1990 and 2020 in Sweden Among 75-, 85-, and 95-Year-Old Women and Men: A Nationwide Study from Sweden.

171. The Impact of Hip Fracture on Geriatric Care and Mortality Among Older Swedes: Mapping Care Trajectories and Their Determinants.

172. High-speed videography of transparent media using illumination-based multiplexed schlieren.

173. Weak crassulacean acid metabolism and other xerophytic adaptive traits in the genus Beaucarnea Lem. (Asparagaceae).

174. Internal fixation or hip replacement for undisplaced femoral neck fractures? Pre-fracture health differences reflect survival and functional outcome.

175. Hospital Length of Stay After Hip Fracture and It's Association With 4-Month Mortality-Exploring the Role of Patient Characteristics.

176. Serum proteome modulations upon treatment provides biological insight on response to treatment in relapsed mantle cell lymphoma.

177. Changes in Athletic Performance in Children Attending a Secondary School with a Physical Activity Profile.

179. Clinical and biological impact of SAMHD1 expression in mantle cell lymphoma.

180. Expression patterns and prognostic potential of circular RNAs in mantle cell lymphoma: a study of younger patients from the MCL2 and MCL3 clinical trials.

181. Scurvy in children - A neglected disease?

182. Comorbidity and the association with 1-year mortality in hip fracture patients: can the ASA score and the Charlson Comorbidity Index be used interchangeably?

183. The association of apolipoproteins with later-life all-cause and cardiovascular mortality: a population-based study stratified by age.

184. Targeted genomic investigations in a population-based cohort of mantle cell lymphoma reveal novel clinically relevant targets.

185. Snapshot multicolor fluorescence imaging using double multiplexing of excitation and emission on a single detector.

186. The Association Between Injurious Falls and Older Adults' Cognitive Function: The Role of Depressive Mood and Physical Performance.

187. Predictors for functional decline after an injurious fall: a population-based cohort study.

188. 'Treat me with respect': transgender persons' experiences of encounters with healthcare staff.

189. Infiltration of CD163-, PD-L1- and FoxP3-positive cells adversely affects outcome in patients with mantle cell lymphoma independent of established risk factors.

190. Trends in Hip Fracture Incidence, Recurrence, and Survival by Education and Comorbidity: A Swedish Register-based Study.

191. Kalirin-RAC controls nucleokinetic migration in ADRN-type neuroblastoma.

192. Immune-related protein signature in serum stratify relapsed mantle cell lymphoma patients based on risk.

193. p53 is associated with high-risk and pinpoints TP53 missense mutations in mantle cell lymphoma.

194. Predictive Performance of the FIF Screening Tool in 2 Cohorts of Community-Living Older Adults.

195. Long sequence single-exposure videography using spatially modulated illumination.

196. Associations of blood pressure with risk of injurious falls in old age vary by functional status: A cohort study.

197. Peak Expiratory Flow and the Risk of Injurious Falls in Older Adults: The Role of Physical and Cognitive Deficits.

198. Relative Age Effect of Sport Academy Adolescents, a Physiological Evaluation.

199. Predicting First-Time Injurious Falls in Older Men and Women Living in the Community: Development of the First Injurious Fall Screening Tool.

200. Ibrutinib inhibits antibody dependent cellular cytotoxicity induced by rituximab or obinutuzumab in MCL cell lines, not overcome by addition of lenalidomide.

Catalog

Books, media, physical & digital resources